Comparison of general characteristics
A total of 2,274 patients were included in this study. According to the number of D3 blastomeres, the patients were divided into six groups: ≤5 (n = 225), 6 (n = 236), 7 (n = 431), 8 (n = 814), 9 (n = 217), and ≥ 10 (n = 351) cells. The baseline demographics of the patient cohort are presented in Table 1. The results showed no significant differences in age, infertility duration, BMI, basal follicle-stimulating hormone level, type of infertility, causes of infertility, scarred uterus, induced ovulation protocol in in vitro fertilization (IVF)/intracytoplasmic sperm injection cycles, fertilization methods, frozen embryo transfer preparation protocol, and endometrial thickness on the day of embryo transfer among the six groups (all p ≥ 0.05). However, the number of oocytes retrieved per cycle, blastomere symmetry, and fragmentation percentage of D3 embryos were significantly different among the six groups (p < 0.05). The number of oocytes retrieved was significantly lower in the ≤ 5-cell group (12.0 ± 4.78) than in the 8-cell group (14.33 ± 4.98). The fragmentation percentage (< 10%) was significantly lower in the ≤ 5-cell (28.9%), 6-cell (31.4%), and 7-cell (27.4%) groups than in the 8-cell (41.0%) group; however, the fragmentation percentage < 10% was higher in the 10-cell (63.8%) group than in the 8-cell group (p < 0.01). In the fragmentation percentage > 25% groups, the results were exactly the opposite.
Table 1
Demographic and treatment characteristics of patients with single blastocyst transfers.
Variable | ≤ 5 cells (n = 225) | 6 cells (n = 236) | 7 cells (n = 431) | 8 cells (n = 814) | 9 cells (n = 217) | ≥ 10 cells (n = 351) | P value |
Maternal age at transfer(years) | 32.63 ± 4.71 | 32.29 ± 4.63 | 32.62 ± 4.13 | 31.96 ± 4.23 | 32.11 ± 4.18 | 32.05 ± 4.31 | 0.093 |
Maternal age at oocyte retrieval(years) | 31. 67 ± 4.71 | 31.30 ± 4.64 | 31.57 ± 4.13 | 31. 00 ± 4.23 | 31.23 ± 4.20 | 31.23 ± 4.32 | 0.197 |
Infertility duration (years) | 5.06 ± 3.55 | 4.78 ± 3.30 | 5.01 ± 2.94 | 4.69 ± 2.93 | 4.74 ± 2.76 | 4.92 ± 2.99 | 0.393 |
Maternal BMI(kg/m2 ) | 21.46 ± 2.68 | 21.32 ± 3.04 | 21.25 ± 2.76 | 21.34 ± 2.93 | 21.40 ± 2.61 | 21.39 ± 2.96 | 0.966 |
Basal FSH((IU/L)) | 6.39 ± 1.73 | 6.26 ± 1.71 | 6.19 ± 1.53 | 6.29 ± 1.57 | 6.21 ± 1.62 | 6.23 ± 1.54 | 0.697 |
Infertility type n (%) | | | | | | | |
Primary infertility | 150(66.7) | 147(62.3) | 253(58.7) | 502(61.7) | 134(61.8) | 214(61.0) | 0.538 |
Secondary infertility | 75(33.3) | 89(37.7) | 178(41.3) | 312(38.3) | 83(38.2) | 137(39.0) | - |
Causes of infertility n (%) | | | | | | | |
Female | 59(26.2) | 77(32.6) | 135(31.3) | 276(33.9) | 66(30.4) | 100 (28.5) | 0.234 |
Male | 122(54.2) | 128(54.2) | 221 (51.3) | 425(52.2) | 110(50.7) | 201(57.3) | 0.601 |
Mixed | 34(15.1) | 24(10.2) | 65(15.1) | 90 (11.1) | 33(15.2) | 39(11.1) | 0.117 |
Unexplained | 10(4.4) | 7(3.0) | 10(2.3) | 23(2.8) | 8(3.7 ) | 11(3.1) | 0.743 |
Scarred uterus, n (%) | | | | | | | |
Yes | 30(13.3) | 34(14.4) | 76(17.6) | 133(16.3) | 37(17.1) | 40 (11.4) | 0.162 |
No | 196(86.7) | 202(85.6) | 355(82.4) | 681(83.7) | 180(82.9) | 311(88.6) | - |
Stimulation protocol, n (%) | | | | | | | |
Agonist | 157(69.8) | 174(73.7) | 310(71.9) | 570(70.0) | 148(68.2) | 247(70.4) | 0.808 |
Antagonist | 68(30.2) | 62(26.3) | 121(28.1) | 244(30.0) | 69(31.8) | 104(29.6) | - |
Fertilization Methods, n (%) | | | | | | | |
IVF | 182(80.9) | 191(80.9) | 360(83.5) | 702(86.2) | 184(86.4) | 284(80.9) | 0.078 |
ICSI | 43(19.1) | 45(19.1) | 71(16.5) | 112(13.8) | 29(13.6) | 67(19.1) | - |
Number of oocytes retrieved | 12.0 ± 4.78* | 12.72 ± 4.80 | 14.14 ± 5.12 | 14.33 ± 4.98 | 13.84 ± 4.90 | 13.85 ± 4.89 | 0.000 |
FET preparation, n (%) | | | | | | | |
Natural cycle | 33(14.7) | 42(17.8) | 71(16.5) | 137(16.8) | 31(14.3) | 52(14.8) | 0.825 |
Hormonal replacement cycle | 175(77.8) | 179(75.8) | 333(77.3) | 635(78.0) | 177(81.6) | 285(81.2) | 0.511 |
Mild Stimulation cycle | 17(7.6) | 15(6.4) | 27(6.3) | 42(5.2) | 9(4.1) | 14(4.0) | 0.396 |
Endometrium thickness on the day of embryo transfer (mm) | 10.66 ± 2.26 | 11.04 ± 2.26 | 10.77 ± 2.25 | 10.83 ± 2.28 | 10.93 ± 2.20 | 10.87 ± 2.18 | 0.535 |
D3 embryo parameters | | | | | | | |
Blastomere symmetry, n (%) | | | | | | | |
Even | 80(35.6) | 75(31.8) | 141(32.7) | 325(39.9) | 68(31.3) | 115(32.8) | 0.027 |
Uneven | 145(64.4) | 161(68.2) | 290(67.3) | 489(60.1) | 149(68.7) | 236(67.2) | - |
Fragmentation percentage, n (%) | | | | | | | |
< 10% | 65(28.9)* | 74(31.4)* | 118(27.4)* | 334(41.0) | 98(45.2) | 224(63.8)* | 0.000 |
10–25% | 97(43.1) | 83(35.2)* | 216(50.1) | 397(48.8) | 94(43.3) | 108(30.8)* | 0.000 |
> 25% | 63(28.0)* | 79(33.5)* | 97(22.5)* | 83(10.2) | 25(11.5) | 19(5.4)* | 0.000 |
Data are presented as mean ± standard deviation or number (percentage).*P < 0.01 represent signifcant diferences in the analysis according to Bonferroni adjustment (using the 8-cell embryo group as reference) . |
Developmental potential of D3 embryos with different numbers of blastomeres in extended culture
The blastocyst formation, available blastocyst, and high-quality blastocyst rates were compared among the six groups to explore the development potential of embryos with different blastomere numbers. Overall, 2,274 cycles of 14,370 embryos were compared. The results revealed that the blastocyst formation and available blastocyst rates increased in groups with cell numbers of up to eight cells (p < 0.001) (Fig. 1) and decreased in the 9- and 10-cell groups compared with those in the 8-cell group (p < 0.001). The high-quality blastocyst rate also increased as the cell number increased; however, the ≥ 10-cell group had a higher high-quality blastocyst rate than the 8-cell group (31.47% vs. 27.44%; p < 0.01; Fig. 1).
Quality of transferred blastocysts developed from D3 embryos with different numbers of blastomeres
The high- and low-quality blastocyst rates, speed of blastocyst development (D5 or D6), and individual blastocyst grades (ICM, TE, and expansion stage) were compared among the six groups to explore the development potential of embryos with different blastomere numbers. The results revealed significant differences in all these comparison parameters among the groups(p < 0.001, Table 2). The proportions of high-quality blastocysts and D5 blastocysts in the ≤ 5-cell, 6-cell, and 7-cell groups significantly decreased compared with those in the 8-cell group (p < 0.01); however, the proportions were not significantly different among the 8-cell, 9-cell, and ≥ 10-cell groups (p ≥ 0.01). Furthermore, as the number of blastomeres in D3 embryos increased, the proportions of blastocysts with an expansion stage of 4 and an ICM grade of A increased; these proportions were significantly higher in the ≥ 10-cell group than in the 8-cell group (p < 0.01); however, these proportions were significantly lower in the 5-cell group than in the 8-cell group (p < 0.01) (Table 2).
Table 2
Quality of transferred blastocysts developed from D3 embryos with different numbers of blastomeres
| ≤ 5 cells (n = 225) | 6 cells (n = 236) | 7 cells (n = 431) | 8 cells (n = 814) | 9 cells (n = 217) | ≥ 10 cells (n = 351) | P value |
Blastocyst quality n (%) | | | | | | | |
High quality | 85(37.8)* | 110(46.6)* | 234(54.3)* | 524(64.4) | 132(60.8) | 250(71.2) | 0.000 |
low quality | 140(62.2)* | 126(53.4)* | 197(45.7)* | 290(35.6) | 85(39.2) | 101(28.8) | 0.000 |
Days of frozen embryo n (%) | | | | | | | |
Day 5 | 92(40.9)* | 137(58.1)* | 306(71.0)* | 690(84.8) | 188(86.6) | 312(88.9) | 0.000 |
Day 6 | 133(59.1)* | 99(41.9)* | 125(29.0)* | 124(15.2) | 29(13.4) | 39(11.1) | 0.000 |
Expansion n (%) | | | | | | | |
3 | 72(32.0)* | 55(23.3) | 100(23.2) | 151(18.6) | 35(16.1) | 27(7.7)* | 0.000 |
4 | 146(64.9)* | 174(73.7) | 320(74.2) * | 644(79.1) | 177(81.6) | 308(87.7)* | 0.000 |
5 | 5(2.2) | 5(2.1) | 9(2.1) | 14(1.7) | 5(2.3) | 13(3.7) | 0.502 |
6 | 2(0.9) | 2(0.8) | 2(0.5) | 5(0.6) | 0(0.0) | 3(0.9) | 0.808 |
Inner cell mass n (%) | | | | | | | 0.000 |
A | 6(2.7)* | 3(1.3)* | 16(3.7)* | 70(8.6) | 15(6.9) | 47(13.4)* | 0.000 |
B | 162(72.0) | 16369.1)* | 344(79.8) | 637(78.3) | 164(75.6) | 259(73.8) | 0.021 |
C | 57(25.3)* | 70(29.7)* | 71(16.5) | 107(13.1) | 38(17.5) | 45(12.8) | 0.000 |
Trophectoderm n (%) | | | | | | | 0.000 |
A | 5(2.2) | 6(2.5) | 14(3.2) | 54(6.6) | 14(6.5) | 31(8.8) | 0.003 |
B | 134(59.6)* | 174(73.7) | 293 (68.0) | 576(70.8) | 156(71.9) | 262(74.6) | 0.000 |
C | 86(38.2)* | 56(23.7) | 124(28.8) | 184(22.6) | 47(21.7) | 58(16.5) | 0.000 |
Data are presented as number(percentage). *P < 0.01 represent signifcant diferences in the analysis according to Bonferroni adjustment (using the 8-cell embryo group as reference) .
Pregnancy outcomes of vitrified–thawed single blastocyst transfer with different numbers of D3 blastomeres
The association between clinical outcomes and the number of D3 blastomeres is shown in Table 3. The LBR was 28.4%, 36.4%, 42.5%, 46.1%, 45.2%, and 58.1% in the ≤ 5-cell, 6-cell, 7-cell, 8-cell, 9-cell, and ≥ 10-cell groups, respectively. Significant differences in the LBR were observed between the groups (p < 0.001). Furthermore, significant differences in the clinical pregnancy and miscarriage rates were observed between the groups (p < 0.05). The clinical pregnancy rate increased as the number of D3 blastomeres increased (p < 0.001). Significant differences in the miscarriage rate were observed among the groups (p < 0.05). The miscarriage rate decreased as the number of D3 blastomeres increased; the miscarriage rates in the ≤ 5-cell, 6-cell, 7-cell, 8-cell, 9-cell, and ≥ 10-cell groups were 23.3%, 18.6%, 14.0%, 15.9%, 13.6%, and 8.9%, respectively. The LBR and clinical pregnancy rate in the ≥ 10-cell group were significantly increased compared with those in the 8-cell group (p < 0.01); however, they were significantly decreased in the ≤ 5-cell group (p < 0.01). Nonetheless, no significant differences in PTM, VPTM, birth weight, and rate of congenital malformations were observed between the groups (p > 0.05).
Table 3
Pregnancy outcomes of vitrified–thawed single blastocyst transfer with different numbers of D3 blastomeres
| ≤ 5 cells (n = 225) | 6 cells (n = 236) | 7 cells (n = 431) | 8 cells (n = 814) | 9 cells (n = 217) | ≥ 10 cells (n = 351) | P value |
Clinical pregnancy, n (%) | 86(38.2)* | 113(47.9) | 214(49.7) | 452(55.5) | 118(54.4) | 225(64.1)* | 0.000 |
Miscarriage, n (%) | 20(23.3) | 21(18.6) | 30(14.0) | 72(15.9) | 16(13.6) | 20(8.9) | 0.023 |
Live birth, n (%) | 64(28.4)* | 86(36.4)* | 183(42.5) | 375(46.1) | 98(45.2) | 204(58.1)* | 0.000 |
Preterm deliveries (<37 weeks) | 3/64(4.7) | 4/86(4.7) | 5/ 183(2.7) | 10/375(2.7) | 6/98(6.1) | 2/204(1.0) | 0.166 |
Very preterm deliveries(<32 weeks) | 0/64(0.0) | 0/86 (0.0) | 2/183(1.1) | 4/375(1.1) | 1/98(1.0) | 1/204 (0.5) | 0.839 |
Birth weight | 3318.75(3219.91,3417.59) | 3195.58(3103.86,3287.30) | 3514.86 (3177.32,3852.41) | 3281.56 (3233.39,3329.73) | 3213.11 (3109.49,3316.74) | 3415.11 (3107.19,3723.02) | 0.369 |
<1500g | 0/64(0.0) | 0/86(0.0) | 1/183(0.5) | 1/375(0.3) | 1/98(1.0) | 1/204(0.5) | 0.869 |
<2500g | 0/64(0.0) | 5/86(5.8) | 5/183(2.7) | 21/375(5.6) | 8/98(8.2) | 8/204(3.9) | 0.125 |
>4000g | 3/64(4.7) | 4/86(4.7) | 15/183(8.2) | 22/375(5.9) | 4/98(4.1) | 10/204(4.9) | 0.679 |
congenital malformations n (%) | 1/86(1.2) | 2/113(1.8) | 1/214(0.5) | 6/452(1.3) | 1/118(0.8) | 1/224(0.4) | 0.771 |
Data are presented as number (percentage) or mean (95% CI).*P < 0.01 represent signifcant diferences in the analysis according to Bonferroni adjustment (using the 8-cell embryo group as reference) .
Pregnancy outcomes of high-quality and low-quality blastocyst frozen embryo transfer cycles
As shown in Table 2, the quality of blastocysts obtained from D3 embryos with different numbers of blastomeres was significantly different. Because the quality of blastocysts is an important factor that determines the success rate of IVF, we demonstrated the association between pregnancy outcomes and D3 cell number in high- and low-quality blastocyst transfer in Table 4. The table shows that in the high-quality blastocyst frozen embryo transfer groups, significant differences in the clinical pregnancy rate and LBR were observed among the groups (p < 0.01), and the LBR was higher in the ≥ 10-cell group but lower in the ≤ 5-cell group than in the 8-cell group (p < 0.01). No significant differences in the miscarriage rate and the rate of congenital malformations were observed among the six groups (p > 0.05). In the low-quality blastocyst frozen embryo transfer groups, significant differences in the clinical pregnancy rate and LBR were observed among the groups (p < 0.05). However, no significant differences were found when each group was compared with the 8-cell embryo group comparisons according to Bonferroni adjustment. Furthermore, the miscarriage rate showed a gradual descending trend with rates of 29.4%, 26.7%, 22.5%, 20.9%, 17.1%, and 7.4% for the ≤ 5-cell, 6-cell, 7-cell, 8-cell, 9-cell, and ≥ 10-cell groups, respectively; however, no statistically significant difference was observed (p > 0.05).
Table 4
Pregnancy outcomes of high-quality and low-quality blastocyst frozen embryo transfer cycles
| ≤ 5 cells | 6 cells | 7 cells | 8 cells | 9 cells | ≥ 10 cells | P value |
High-quality blastocysts(n) | 85 | 110 | 234 | 524 | 132 | 250 | |
Clinical pregnancy, n (%) | 35(41.2)* | 68(61.8) | 134(57.3) | 318(60.7) | 77(58.3) | 171(68.4) | 0.001 |
Miscarriage, n (%) | 5(14.3) | 9 (13.2) | 12((9.0) | 44(13.8) | 9(11.7) | 16(9.4) | 0.605 |
Live birth, n (%) | 30(35.3)* | 57(51.8) | 122(52.1) | 270(51.5) | 66(50.0) | 154(61.6)* | 0.002 |
Genetic disorder/malformations n (%) | 0(0.0) | 1(1.5) | 0(0.0) | 5(1.6) | 0(0.0) | 1(0.6) | 0.505 |
Low-quality blastocysts(n) | 140 | 126 | 197 | 290 | 85 | 101 | |
Clinical pregnancy, n (%) | 51(36.4) | 45(35.7) | 80(40.6) | 134(46.2) | 41(48.2) | 54(53.5) | 0.031 |
Miscarriage, n (%) | 15(29.4) | 12(26.7) | 18(22.5) | 28(20.9) | 7(17.1) | 4(7.4) | 0.087 |
Live birth, n (%) | 34(24.3) | 29(23.0)* | 61(31.0) | 105(36.2) | 32(37.6) | 50(49.5) | 0.000 |
congenital malformations (%) | 1(1.8) | 1(2.3) | 1(1.3) | 1(0.7) | 1(2.4) | 0(0.0) | 0.855 |
Data are presented as number (percentage). *P < 0.01 represent signifcant diferences in the analysis according to Bonferroni adjustment (using the 8-cell embryo group as reference) .
Results of logistic regression analysis of the clinical pregnancy rate and LBR
The results of logistic regression analysis of the clinical pregnancy rate and LBR after adjusting for some confounding variables are shown in Table 5. The ≥ 10-cell group was associated with higher LBR than the 8-cell group (aOR, 1.612; 95% CI, 1.230–2.112; p = 0.001). Conversely, the LBR was significantly lower in the ≤ 5-cell group (aOR, 0.627; 95% CI, 0.442–0.891; p = 0.009). The clinical pregnancy rates were similar to the LBR in the ≤ 5-cell and ≥ 10-cell groups. Moreover, age, infertility duration, endometrial thickness, blastocyst expansion stage of 4, ICM, and TE grade also significantly affected the clinical pregnancy rate and LBR. Scarred uterus only affected the LBR (aOR, 0.744; 95% CI, 0.577–0.959; p = 0.022).
Table 5
Results of logistic regression analysis of the clinical pregnancy rate and LBR
| Clinical pregnancy rate | Live birth rate |
| aOR | 95% CI | P‑value | aOR | 95% CI | P‑value |
D3 blastomeres number | | |
≤ 5 cells | 0.693 | 0.498,0.965 | 0.030 | 0.627 | 0.442,0.891 | 0.009 |
6 cells | 0.909 | 0.666,1.239 | 0.545 | 0.810 | 0.588,1.117 | 0.199 |
7 cells | 0.916 | 0.716,1.171 | 0.483 | 0.989 | 0.770,1.269 | 0.929 |
8 cells | Reference | | | Reference | | |
9 cells | 0.976 | 0.715,1.332 | 0.879 | 1.010 | 0.739,1.382 | 0.948 |
≥ 10 cells | 1.364 | 1.037,1.793 | 0.026 | 1.612 | 1.230,2.112 | 0.001 |
Maternal age at transfer(years) | 0.967 | 0.944,0.991 | 0.007 | 0.962 | 0.939,0.986 | 0.002 |
Infertility duration (years) | 0.965 | 0.934,0.997 | 0.031 | 0.956 | 0.924,0.990 | 0.010 |
Type of infertility | | |
Primary infertility | Reference | | | Reference | | |
Second infertility | 0.958 | 0.787,1.165 | 0.665 | 0.961 | 0.788,1.174 | 0.699 |
Maternal BMI(kg/m2 ) | 0.996 | 0.966,1.027 | 0.792 | 0.996 | 0.965,1.027 | 0.787 |
Scarred uterus, n (%) | | |
NO | Reference | | | Reference | | |
Yes | 0.790 | 0.619,1.010 | 0.060 | 0.744 | 0.577,0.959 | 0.022 |
Stimulation protocol, n (%) | | |
Agonist | Reference | | | Reference | | |
Antagonist | 1.158 | 0.956,1.404 | 0.133 | 1.127 | 0.963,1.427 | 0.227 |
Fertilization protocol, n (%) | |
IVF | Reference | | | Reference | | |
ICSI | 0.913 | 0.719,1.159 | 0.456 | 0.998 | 0.783,1.272 | 0.986 |
Number of oocytes retrieved | 1.014 | 0.996,1.033 | 0.132 | 1.016 | 0.997,1.035 | 0.091 |
FET preparation | | |
Natural cycle | Reference | | | Reference | | |
Hormonal replacement cycle | 1.009 | 0.797,1.278 | 0.941 | 0.980 | 0.770,1.247 | 0.867 |
Mild Stimulation cycle | 0.956 | 0.619,1.478 | 0.840 | 1.062 | 0.679,1.662 | 0.793 |
Endometrium thickness on the day of embryo transfer (mm) | 1.048 | 1.007,1.091 | 0.020 | 1.054 | 1.013,1.097 | 0.010 |
Blastomere symmetry of day 3 embryo | | |
even | Reference | | | Reference | | |
uneven | 0.902 | 0.746,1.091 | 0.287 | 0.843 | 0.696,1.021 | 0.081 |
Fragmentation of day 3 embryo | | |
3 | Reference | | | Reference | | |
2 | 0.870 | 0.658,1.151 | 0.329 | 0.765 | 0.584,1.002 | 0.051 |
1 | 0.861 | 0.662,1.120 | 0.265 | 0.751 | 0.564,1.000 | 0.050 |
Blastocyst expansion | | |
3 | Reference | | | Reference | | |
4 | 1.395 | 1.111,1.752 | 0.004 | 1.350 | 1.067,1.709 | 0.012 |
5 | 0.923 | 0.490,1.739 | 0.803 | 0.848 | 0.438,1.643 | 0.625 |
6 | 0.582 | 0.170,1.996 | 0.390 | 0.522 | 0.133,2.045 | 0.351 |
Inner cell mass | | |
A | 3.013 | 1.935,4.691 | 0.000 | 3.686 | 2.392,5.681 | 0.000 |
B | 1.701 | 1.318,2.195 | 0.000 | 2.316 | 1.765,3.040 | 0.000 |
C | Reference | | | Reference | | |
Trophectoderm | | |
A | 1.610 | 1.041,2.488 | 0.032 | 1.538 | 1.005,2.354 | 0.048 |
B | 1.479 | 1.188,1.839 | 0.000 | 1.557 | 1.246,1.946 | 0.000 |
C | Reference | | | Reference | | |
Days of frozen embryo | | |
D5 | Reference | | | Reference | | |
D6 | 0.779 | 0.618,0.981 | 0.034 | 0.849 | 0.668,1.078 | 0.179 |